Initiating Mealtime Ultra-Rapid Acting Insulin (Afrezza) in Uncontrolled Type 2 Diabetes Patients
Clinical trial NCT03324776 · COMPLETED
Trial details
- NCT number
- NCT03324776
- Sponsor
- Model Clinical Research LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-16
- Primary completion
- 2020-06-10
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.